Drug profile · INN
pirfenidone
ARX-PIRFENIDONE
pirfenidone (ARX-PIRFENIDONE) is a unknown. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — pirfenidone
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L04)
- Route
- ORAL
- Patents
- 0
- Programs
- 6
- Data quality
- 0.89
Quick answer
pirfenidone (ARX-PIRFENIDONE) is a unknown. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
| PMDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is pirfenidone?
pirfenidone (ARX-PIRFENIDONE) is a unknown. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pirfenidone?
ARX-PIRFENIDONE is a marketed brand name for pirfenidone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pirfenidone?
pirfenidone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.